GSK•benzinga•
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
Summary
Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock rally.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 17, 2025 by benzinga